Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DKFMA-102 by Dongkook Pharmaceutical for Prostate Cancer: Likelihood of Approval
DKFMA-102 is under clinical development by Dongkook Pharmaceutical and currently in Phase III for Prostate Cancer. According to GlobalData, Phase...